Video

AHA/ACC prevention guidelines: Clinician perspective


 

Soon after the AHA/ACC cardiovascular prevention guidelines were released, they were engulfed in criticism and controversy, especially for the new risk calculator. Meanwhile, physicians have to decide how to incorporate the updated guidelines into their practice.

In this interview, Dr. Eugenia Gianos, director of Preventive Cardiology Consult Service at NYU Langone Medical Center, New York, shares her thoughts on the risk calculator, the guidelines, and their impact on practice.

Recommended Reading

Obesity paradox may exist in hypertensive patients with diabetes
MDedge Family Medicine
Large U.K. database shows sulfonylurea mortality link
MDedge Family Medicine
ACCORD: Younger, not older, age linked to higher cardiovascular death rates
MDedge Family Medicine
FDA moves to reduce or remove unhealthy trans fats from foods
MDedge Family Medicine
CV events scuttle bardoxolone for diabetic kidney disease
MDedge Family Medicine
Combined angiotensin inhibition raises hyperkalemia, acute kidney injury risks
MDedge Family Medicine
ACC-AHA cardiovascular prevention guidelines drop cholesterol treatment goals
MDedge Family Medicine
New prevention guidelines bring welcome changes
MDedge Family Medicine
Abandon LDL targets? Not yet
MDedge Family Medicine
Guideline authors, AHA-ACC leaders confident in risk calculator
MDedge Family Medicine